Walgreens announces expansion into cell and gene therapy services in the U.S., aiming to provide specialized care for patients with chronic, rare, or complex conditions. The move includes the launch of a new business unit and the opening of a facility in Pittsburgh dedicated to cell and gene therapies, reflecting the growing importance of specialty pharmacies in the healthcare system. [ad_1] A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday said…
Walgreens Spearheads Advancement of Cell and Gene Therapies in Patient Care Expansion
